Cargando…
Development and Characterization of Innovative Multidrug Nanoformulation for Cardiac Therapy
For several decades, various peptides have been under investigation to prevent ischemia/reperfusion (I/R) injury, including cyclosporin A (CsA) and Elamipretide. Therapeutic peptides are currently gaining momentum as they have many advantages over small molecules, such as better selectivity and lowe...
Autores principales: | Gendron, Amandine, Domenichini, Séverine, Zanna, Sandrine, Gobeaux, Frédéric, Piesse, Christophe, Desmaële, Didier, Varna, Mariana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003764/ https://www.ncbi.nlm.nih.gov/pubmed/36902927 http://dx.doi.org/10.3390/ma16051812 |
Ejemplares similares
-
New Nanoparticle Formulation for Cyclosporin A: In Vitro Assessment
por: Gendron, Amandine, et al.
Publicado: (2021) -
Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents
por: Dormont, Flavio, et al.
Publicado: (2020) -
Ampicillin Silver Nanoformulations against Multidrug resistant bacteria
por: Khatoon, Nafeesa, et al.
Publicado: (2019) -
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
por: Bessone, Federica, et al.
Publicado: (2021) -
Design and Characterization of Chitosan Nanoformulations for the Delivery of Antifungal Agents
por: Calvo, Natalia L., et al.
Publicado: (2019)